GeneDx Holdings (WGS) EBT Margin (2020 - 2026)

GeneDx Holdings has disclosed EBT Margin across 7 years of filings, most recently posting 61.04% for Q1 2026.

• In Q1 2026, EBT Margin fell 5406.0% year-over-year to 61.04%; the TTM figure through Mar 2026 stood at 17.5% (down 587.0% YoY), while the FY2025 annual figure was 4.94%, up 1229.0% from the prior year.
• EBT Margin retreated to 61.04% in Q1 2026, from 15.07% in the prior quarter.
• Over the last five years, EBT Margin for WGS reached as high as 10.29% in Q2 2025 and fell as low as 503.13% in Q4 2022.
• The 5-year median for EBT Margin is 45.6% (2023), against an average of 96.09%.
• Annual changes were most pronounced in 2022 — EBT Margin plunged 43361 bps — and 2023, when it jumped 45753 bps.
• A 5-year view of EBT Margin shows it stood at 503.13% in 2022, then surged by 91 bps to 45.6% in 2023, then soared by 112 bps to 5.66% in 2024, then plunged by 366 bps to 15.07% in 2025, then sank by 305 bps to 61.04% in 2026.
• According to Business Quant data, EBT Margin over the past three periods registered 61.04%, 15.07%, and 6.33% for Q1 2026, Q4 2025, and Q3 2025 respectively.